Dioxisept, 1% 10 ml 10 pcs

Dioxidine is a broad spectrum antibacterial agent of the group of quinoxaline derivatives, it has chemotherapeutic activity against infections caused by proteus vulgaris, dysentery bacillus, Klebsiella, pseudomonella, salmonellae, staphylococci, streptococci, pathogenic anaerobes (including gas gangrene pathogens.including causative agents of gas gangrene), acts on bacterial strains resistant to other chemopreparations, including antibiotics.

The development of drug resistance of bacteria is possible. When administered intravenously it is characterized by low therapeutic latitude, in connection with which compliance with the recommended dosages must be strictly observed.

The treatment of burn and purulent-necrotic wounds promotes faster cleansing of the wound surface, stimulates reparative regeneration and marginal epithelization and has a favourable effect on the course of the wound process.

Indications

Purulent processes in the chest and abdominal cavity: purulent pleurisy, pleural empyema, peritonitis, cystitis, gallbladder empyema, prevention of infectious complications after bladder catheterization; wound and burn infections (superficial and deep purulent wounds of various locations, long-term non-healing wounds and trophic ulcers, soft tissue phlegmon, infected burns, purulent wounds with osteomyelitis), wounds with deep purulent cavities (lung abscess, soft tissue abscesses, pelvic cellulitis, postoperative wounds of the urinary and biliary tract, purulent mastitis), pustular skin diseases.

Pharmacological effect

Dioxidin is a broad-spectrum antibacterial drug from the group of quinoxaline derivatives, has chemotherapeutic activity against infections caused by Proteus vulgaris, dysentery bacillus, Klebsiella, Pseudomonas aeruginosa, salmonella, staphylococci, streptococci, pathogenic anaerobes (including causative agents of gas gangrene), acts on strains of bacteria resistant to other chemotherapy drugs, including antibiotics.

The development of drug resistance in bacteria is possible. When administered intravenously, it is characterized by a small therapeutic width, and therefore strict adherence to the recommended doses is necessary.

Treatment of burn and purulent-necrotic wounds promotes faster cleansing of the wound surface, stimulates reparative regeneration and marginal epithelization, and has a beneficial effect on the course of the wound process.

Active ingredient

Hydroxymethylquinoxaline dioxide

Composition

Active ingredient:

Hydroxymethylquinoxaline dioxide10 mg

Contraindications

Hypersensitivity, adrenal insufficiency (including a history), pregnancy, lactation, children (up to 18 years).

Side Effects

Allergic reactions, headache, chills, hyperthermia, nausea, vomiting, diarrhea, muscle twitching.

Storage conditions

In a place protected from light, at a temperature of 15–25 °C

Shelf life

2 years

Manufacturer

Dalkhimfarm, Russia